表紙
市場調査レポート

重症急性呼吸器症候群(SARS)コロナウイルス感染症:世界の治験レビュー

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322154
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
重症急性呼吸器症候群(SARS)コロナウイルス感染症:世界の治験レビュー Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 58 Pages
概要

当レポートでは、重症急性呼吸器症候群(SARS)コロナウイルス感染症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 重症急性呼吸器症候群(SARS)コロナウイルス感染症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:感染症の治験における重症急性呼吸器症候群(SARS)コロナウイルス感染症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症の治験における重症急性呼吸器症候群(SARS)コロナウイルス感染症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

重症急性呼吸器症候群(SARS)コロナウイルス感染症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Pharmstandard
    • Hemispherx Biopharma, Inc.
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • National Taiwan University Hospital
    • Queen Mary Hospital
    • Hospital Authority
    • Queen's University

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2495CTIDB

GlobalData's clinical trial report, "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014" provides data on the Severe Acute Respiratory Syndrome (SARS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Acute Respiratory Syndrome (SARS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pharmstandard
      • Clinical Trial Overview of Pharmstandard
      • Hemispherx Biopharma, Inc.
      • Clinical Trial Overview of Hemispherx Biopharma, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Queen Mary Hospital
      • Clinical Trial Overview of Queen Mary Hospital
      • Hospital Authority
      • Clinical Trial Overview of Hospital Authority
      • Queen's University
      • Clinical Trial Overview of Queen's University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmstandard, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hemispherx Biopharma, Inc., 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*

List of Figures

  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top